Celldex Therapeutics Inc (CLDX)
36.30
+0.04
(+0.11%)
USD |
NASDAQ |
Apr 26, 16:00
36.28
-0.02
(-0.04%)
After-Hours: 20:00
Celldex Therapeutics Enterprise Value: 1.603B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 1.603B |
April 24, 2024 | 1.646B |
April 23, 2024 | 1.688B |
April 22, 2024 | 1.748B |
April 19, 2024 | 1.700B |
April 18, 2024 | 1.730B |
April 17, 2024 | 1.792B |
April 16, 2024 | 1.734B |
April 15, 2024 | 1.760B |
April 12, 2024 | 1.771B |
April 11, 2024 | 1.861B |
April 10, 2024 | 1.767B |
April 09, 2024 | 1.847B |
April 08, 2024 | 1.798B |
April 05, 2024 | 1.789B |
April 04, 2024 | 1.788B |
April 03, 2024 | 1.832B |
April 02, 2024 | 1.877B |
April 01, 2024 | 1.904B |
March 28, 2024 | 1.923B |
March 27, 2024 | 1.912B |
March 26, 2024 | 1.871B |
March 25, 2024 | 1.893B |
March 22, 2024 | 1.924B |
March 21, 2024 | 1.869B |
Date | Value |
---|---|
March 20, 2024 | 1.933B |
March 19, 2024 | 1.840B |
March 18, 2024 | 1.866B |
March 15, 2024 | 1.925B |
March 14, 2024 | 1.953B |
March 13, 2024 | 2.110B |
March 12, 2024 | 2.151B |
March 11, 2024 | 2.178B |
March 08, 2024 | 2.255B |
March 07, 2024 | 2.201B |
March 06, 2024 | 2.290B |
March 05, 2024 | 2.372B |
March 04, 2024 | 2.411B |
March 01, 2024 | 2.477B |
February 29, 2024 | 2.263B |
February 28, 2024 | 2.448B |
February 27, 2024 | 2.430B |
February 26, 2024 | 2.272B |
February 23, 2024 | 1.687B |
February 22, 2024 | 1.669B |
February 21, 2024 | 1.685B |
February 20, 2024 | 1.729B |
February 16, 2024 | 1.715B |
February 15, 2024 | 1.634B |
February 14, 2024 | 1.603B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-51.61M
Minimum
Jun 12 2019
2.477B
Maximum
Mar 01 2024
916.77M
Average
1.004B
Median
Enterprise Value Benchmarks
ThermoGenesis Holdings Inc | 9.147M |
Perspective Therapeutics Inc | 931.55M |
Electromed Inc | 128.80M |
Xtant Medical Holdings Inc | 133.46M |
Asensus Surgical Inc | 44.48M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -43.31M |
Revenue (Quarterly) | 4.131M |
Total Expenses (Quarterly) | 39.26M |
EPS Diluted (Quarterly) | -0.84 |
Profit Margin (Quarterly) | -1.05K% |
Earnings Yield | -8.05% |
Normalized Earnings Yield | -8.127 |